Inhaled dopamine agonists for late stage Parkinsonism

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$1,619,220.00
Award Year:
2004
Program:
SBIR
Phase:
Phase II
Contract:
2R44NS045505-02
Agency Tracking Number:
NS045505
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
ALEXZA MOLECULAR DELIVERY CORPORATION
ALEXZA MOLECULAR DELIVERY CORPORATION, 1001 E MEADOW CIR, PALO ALTO, CA, 94303
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 PATRIK Munzar
 (650) 687-3900
Business Contact
Phone: (650) 687-3902
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Many patients in the later stages of Parkinson's disease experience periods of acute immobility ("off' periods) that substantially decrease their quality of life. The most effective pharmacological treatments for t

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government